The downregulation of ALKBH5 has been identified as a significant method for restraining the proliferation and malignancy of lung adenocarcinoma cells through decreasing the translation efficiency of FOXM1 mediated by m6A modification [76]. The gene discussed is ALKBH5; the disease is lung adenocarcinoma.